Evidence map›Paper›PMID 40082293›Full record

ArticleMedical molecular morphology2025

Large number of CD68

Hazuki Kashiwagi, Kengo Shigehara, Terufumi Kubo, Yoshihiko Hirohashi, Tasuku Mariya, Kazuhiko Matsuo, Tomoyuki Minowa, Shin-Ichi Ishioka, Kenji Murata, Takayuki Kanaseki and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical molecular morphology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hazuki KashiwagiDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Kengo ShigeharaDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Terufumi KuboDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan. kuboteru@sapmed.ac.jp.ORCID http://orcid.org/0000-0001-9274-2551
Yoshihiko HirohashiDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan. hirohash@sapmed.ac.jp.
Tasuku MariyaDepartment of Obstetrics and Gynecology, Sapporo Medical University, School of Medicine, Sapporo, Japan.
Kazuhiko MatsuoSapporo Clinical Laboratory Inc., Sapporo, Japan.
Tomoyuki MinowaDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Shin-Ichi IshiokaDepartment of Obstetrics and Gynecology, Sapporo Medical University, School of Medicine, Sapporo, Japan.
Kenji MurataDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Takayuki KanasekiDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Tomohide TsukaharaDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Tadashi HasegawaDepartment of Surgical Pathology, Sapporo Medical University Hospital, Sapporo, Japan.
Tsuyoshi SaitoDepartment of Obstetrics and Gynecology, Sapporo Medical University, School of Medicine, Sapporo, Japan.
Toshihiko TorigoeDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Placenta accreta spectrum (PAS) is a serious disease leading to complications and maternal death. The objective of the study was to characterize the placental villi and blood vessels of PAS villi histopathologically. We investigated 10 cases of PAS (five cases of placenta increta, two cases of placenta accreta, and three cases of placenta percreta) histologically. Immunohistochemical staining using anti-CD68 or anti-CD163 antibodies was performed to detect and count Hofbauer cells. Immunohistochemical staining with an anti-CD34 antibody was used to detect vascular endothelial cells, and the number and area of vessels were analyzed. The numbers of CD68-positive or CD163-positive Hofbauer cells were larger in PAS cases compared with control cases. The vascular area in villi was smaller in PAS cases compared with control cases. The number of blood vessels in villi was slightly higher in PAS cases than in control cases. The numbers of Hofbauer cells and vessels in villi were larger in PAS cases compared with control cases, whereas the area of vessels in villi was smaller in PAS cases compared with control cases. Although their biological meaning is elusive, these findings provide novel insights into the pathogenesis of PAS, particularly regarding the role of Hofbauer cells in immune-suppressive role and angiogenesis and the alterations in vascular structure and hemodynamics in the chorionic villi.

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticChorionic VilliPlacenta AccretaReceptors, Cell SurfaceAdultCD163 AntigenCD68 MoleculeFemaleHumansImmunohistochemistryPlacentaPregnancyAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCD68 antigen, humanCD68 MoleculeReceptors, Cell SurfaceHofbauer cellsPlacenta accreta spectrumVascular structure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.